St. Jude Medical rebounds after “Greek tragedy” | Wall Street Beat

March 7, 2012 By MassDevice staff Leave a Comment

Shares of St. Jude Medical (NYSE:STJ) clawed back some of the value lost yesterday in what 1 waggish analyst termed a “Greek tragedy.”

STJ shares closed down 3.3% yesterday at $39.96 when the company revealed a $56 million writedown after a Greek distributor failed to pay up for an estimated 2 years worth of sales.

Calling it a "Greek tragedy," Citigroup analyst Matthew Dodds wrote a research note to investors that St. Jude waited longer than other companies to write down its Greek receivables.

"[St. Jude] has not disclosed how long it has been since this distributor has paid them, but our math suggests $56 million is at least 2 years’ worth of sales in Greece based on competitor sales basis (pre-crisis)," Dodds wrote.

The Greek government, the International Monetary Fund and the European Union inked a deal in February to resolve that country’s massive debt crisis.

"This agreement, among other macroeconomic and factors specific to the distributor, negatively impacted the solvency and liquidity of the company’s Greek distributor, raising significant doubt regarding the collectability of our outstanding accounts receivable balance of approximately $56 million," St. Jude said in the SEC filing. "We have also experienced delays in the collectability of receivables in certain European member states, particularly in Southern Europe. Although we still expect to fully collect these receivables, there can be no assurances that additional negative economic disruptions and slowdowns in Europe may result in us not fully collecting these receivables, adversely affecting our cash flows, financial position and results of operations. Additional prolongation of the economic disruptions in Europe may negatively impact reimbursement rates and procedural volumes and adversely affect our business and results of operations."

STJ shares were trading at $40.91 as of about 11:50 today, up 2.4% on the day.

Nuance to pay $300M to Transcend

Nuance Communications agreed to pay $300 million to acquire medical transcription and speech editing services provider Transcend Services. Read more

Report: Syneron in talks to buy TransPharma

Syneron Medical (NSDQ:ELOS) is in talks to purchase transdermal drug delivery firm TransPharma Medical for $15 million, according to an Israeli news outlet. Read more

ACT’s 2011 cash burn ramps up on clinical trials

Advanced Cell Technology (OTC:ACT) said its cash burn went up 55% last year, as it ramped up the first -ever clinical trial involving human embryonic stem cells. Read more

CareFusion wins $75M DoD contract

CareFusion (NYSE:CFN) won a $75 million contract from the U.S. Defense Dept. for "medical equipment, maintenance and/or spare parts/repair parts of medical equipment. Read more

Amgen closes Micromet tender offer

Amgen (NSDQ:AMGN) said it now owns more than 88% of Micromet (NSDQ:MITI) and plans to buy the rest by the end of the day, when MITI shares will cease trading publicly and the $11-per-share, $1.16 billion offer closes. Read more

Allezoe deals Organ Transport Systems back to Healthcare of Today
Allezoe Medical Holdings (OTC:ALZM) agreed to reverse its takeover of Organ Transport Systems from Healthcare of Today Inc. after it realized it will take about $10 million to get the technology ready for market. Read more

Hill-Rom raises Q2 dividend
Hill-Rom Holdings (NYSE:HRC) raised its 2nd-quarter dividend by 11 percent to 12.5 cents per share, payable March 30. Read more

Baxter issues Q4 dividend
Baxter International (NYSE:BAX) declared a quarterly dividend of 33.5 cents per share, payable April 2. Read more

Nordion issues Q4 dividend

Nordion (NYSE:NDZ) declared a quarterly dividend of 10 cents per share, payable April 5. Read more

Funding Roundup

Analysts’ ups and downs

Baxter (NYSE:BAX): RBC Capital maintains "outperform" rating.
Mako Surgical (NSDQ:MAKO): Leerink Swann maintains "market perform" rating, raises price target from $35 to $39.
Zeltiq (NSDQ:ZLTQ): Goldman Sachs downgrades from "buy" to "neutral," lowers price target from $19 to $8.50.

RSNA 2019: 7 radiology innovations you need to know
Nearly 53,000 people attended the 2019 Radiological Society of North America annual meeting in Chicago last week. And they heard the same acronym over and over again: AI. Exhibitors at the conference touted their artificial-intelligence-enhanced technology at every turn, claiming to make images clearer, sharper, easier to use and powerful enough to help clinicians make… […]
Employees say Intuitive Surgical, J&J, Stryker best places to work in 2020
Intuitive Surgical (NSDQ:ISRG), Johnson & Johnson (NYSE:JNJ) and Stryker (NYSE:SYK) were recently named as Glassdoor’s employees’s choice of Best Places to Work in 2020. Each year, Glassdoor uses feedback that employees have shared on the website over the past year to compile a list of the best places to work in 2020. Employee reviews provide Glassdoor with insights into job and… […]
Biolase lands 510(k) for dental hygiene laser
Biolase (NSDQ:BIOL) this week announced it has received FDA 510(k) clearance for its Epic Hygiene dental laser. The laser system allows dental hygienists to manage non-surgical periodontitis and increase clinical production. It offers a step-by-step clinical protocol with pocket therapy and perio debridement for easy implementation. Get the full story on our sister site, MassDevice. The […]
Mayo Clinic, W.L. Gore team up on stem cell therapy treatments
Mayo Clinic and W. L. Gore & Associates have announced a partnership to develop implantable cell therapies to treat debilitating conditions with no cure. The for-profit company, Avobis Bio, will combine a patient’s own stem cells with bioabsorbable scaffolds to stimulate the healing of perianal fistulas, painful tunneling wounds that affect patients with Crohn’s disease.… […]
Toray Industries touts polymer optical fiber
Toray Industries said today that its Raytela polymer optical fiber provides for high-quality imaging in the minimally invasive medical device market. Raytela can negotiate tight 9mm radius bends, making it useful for devices used in endoscopy, uretroscopy, ophthalmic surgery and other procedures that require smaller devices that can navigate more tortuous paths than previously available,… […]
Report: EtO blood levels higher in Illinois neighbors of Medline sterilization plant
This article has been updated with comments from Medline Industries. People who live about a mile away from a Medline device sterilization plant in Waukegan, Ill. have blood levels of the cancer-causing gas ethylene oxide that are about 50% higher than those who live farther away, according to a report by WebMD and Georgia Health… […]
Glooko gains ISO certification for California, Sweden sites
Diabetes software company Glooko announced today that its Mountain View, Calif., and Gothenburg, Sweden, sites have received joint ISO 13485:2016 certification from accredited certification body Intertek Testing Services. ISO 13485 describes the requirements for comprehensive practices and procedures for the design, development, production and delivery of medical devices, including digital health software. To become ISO… […]
FDA details framework for abbreviated 510(k) medical device review pathway
By Stewart Eisenhart, Emergo Group The US Food and Drug Administration has published a high-level framework for its Safety and Performance Based Pathway, an expedited 510(k) premarket review process for qualifying medical devices announced earlier in 2019. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are… […]
Drug or device? FDA loses this argument for now
This article has been updated with comments from an attorney for Genus Medical Technologies. A federal judge has temporarily blocked an attempt by the FDA to regulate a barium sulfate product ingested before imaging as a drug. The decision counts as at least a partial win for Genus Medical Technologies (St. Louis), maker of the… […]
Greenlight Guru updates change management capabilities of QMS
Greenlight Guru said today that it has added updates to the change management capabilities  of its medical device quality management system (MDQMS). The update was designed to improve traceability and efficiency associated with product and process changes, according to the Indianapolis-based company. It includes advanced workflow efficiencies to identify, assess and track the items affected… […]
Medical device excise tax would reduce R&D spending, report says
The medical device excise tax will reduce research and development spending and impede innovation if reinstated in 2020, according to a report from Minnesota trade group Medical Alley Association. In the report, Medical Alley surveyed its members that will be affected by the return of the tax on Jan. 1, 2020. About 83% of survey respondents… […]